X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
index medicus (14) 14
female (13) 13
male (13) 13
animals (12) 12
middle aged (11) 11
adult (10) 10
biochemistry & molecular biology (10) 10
oncology (10) 10
aged (9) 9
rheumatology (8) 8
base sequence (7) 7
genetics & heredity (7) 7
molecular sequence data (7) 7
scleroderma (7) 7
cancer (6) 6
databases, factual (6) 6
disease progression (6) 6
dna mutational analysis (6) 6
escherichia-coli (6) 6
eular scleroderma trials (6) 6
klinikai orvostudományok (6) 6
mutagenesis (6) 6
orvostudományok (6) 6
research (6) 6
cell biology (5) 5
immunology (5) 5
mortality (5) 5
prognosis (5) 5
risk factors (5) 5
scleroderma, systemic - complications (5) 5
supf (5) 5
survival (5) 5
systemic scleroderma (5) 5
systemic sclerosis (5) 5
care and treatment (4) 4
dna, bacterial - drug effects (4) 4
escherichia coli - genetics (4) 4
gene expression (4) 4
hypertension (4) 4
inflammation (4) 4
lomustine - toxicity (4) 4
mice (4) 4
mutation (4) 4
mutation spectrum (4) 4
prospective studies (4) 4
studies (4) 4
alkylating-agents (3) 3
analysis (3) 3
cardiovascular diseases - etiology (3) 3
ccnu (3) 3
cells, cultured (3) 3
clinical trials (3) 3
cohort (3) 3
data bases (3) 3
disease (3) 3
dna repair - drug effects (3) 3
dna-repair (3) 3
epidemiology (3) 3
fibrosis (3) 3
follow-up studies (3) 3
genes, p53 (3) 3
health aspects (3) 3
immune response (3) 3
kidney diseases - etiology (3) 3
medical prognosis (3) 3
multivariate analysis (3) 3
mutagens - toxicity (3) 3
neutrophils (3) 3
organ involvement (3) 3
p53 (3) 3
point mutation (3) 3
promoter regions, genetic (3) 3
risk-factors (3) 3
saccharomyces cerevisiae - genetics (3) 3
scleroderma, diffuse - pathology (3) 3
scleroderma, systemic - physiopathology (3) 3
severity of illness index (3) 3
sex factors (3) 3
skin ulcer - etiology (3) 3
therapy (3) 3
usage (3) 3
4-nitroquinoline-1-oxide - toxicity (2) 2
abasic sites (2) 2
abridged index medicus (2) 2
acetylcysteine (2) 2
activation (2) 2
adenine - metabolism (2) 2
adenosine a2 receptor antagonists - pharmacology (2) 2
adenosine a2 receptor antagonists - therapeutic use (2) 2
age of onset (2) 2
angiogenesis (2) 2
antineoplastic agents, alkylating - toxicity (2) 2
autoantibodies (2) 2
autoantibodies - blood (2) 2
base sequence - drug effects (2) 2
carcinogen 4-hydroxyaminoquinoline 1-oxide (2) 2
cardiovascular diseases - physiopathology (2) 2
cell line, tumor (2) 2
cell survival - drug effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Handbook of Experimental Pharmacology, ISSN 0171-2004, 2017, Volume 241, pp. 1 - 19
Journal Article
Handbook of experimental pharmacology, ISSN 0171-2004, 2017, Volume 241, p. 121
Mast cells and basophils represent the most relevant source of histamine in the immune system. Histamine is stored in cytoplasmic granules along with other... 
Histamine - metabolism | Animals | Cytokines - metabolism | Hypersensitivity - metabolism | Receptors, G-Protein-Coupled - metabolism | Immune System - metabolism | Humans | Histamine Release - physiology | Mast Cells - metabolism | Basophils - metabolism
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0199740
Background Neutrophil functions have long been regarded as limited to acute inflammation and the defense against microbes. The role(s) of neutrophils in cancer... 
INFLAMMATORY MICROENVIRONMENT | CELL RESPONSES | ANGIOGENESIS | GM-CSF | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | MAST-CELLS | IN-VIVO | TUMOR-ASSOCIATED MACROPHAGES | RECEPTOR | TO-LYMPHOCYTE RATIO | Antigens, CD - immunology | GPI-Linked Proteins - immunology | CD11b Antigen - immunology | Coculture Techniques | Humans | Neutrophils - immunology | Cell Adhesion Molecules - immunology | Cell Survival - immunology | Immunity, Innate | Neutrophil Infiltration | Reactive Oxygen Species - immunology | Thyroid Neoplasms - immunology | Cell Line, Tumor | Chemotaxis - immunology | Interleukin-8 - immunology | Neutrophils - pathology | Thyroid Neoplasms - pathology | Cell proliferation | Care and treatment | Thyroid cancer | Cytokines | Patient outcomes | Development and progression | Research | Risk factors | Biotechnology | Reactive oxygen species | Effector cells | Innate immunity | Activation | Metastasis | Matrix metalloproteinase | Immunity | Clinical outcomes | Proteins | Angiogenesis | Cell activation | Immunology | Lymphocytes | Colony-stimulating factor | Metalloproteinase | Conditioning | Vascular endothelial growth factor | Interleukin 8 | Public health | Thyroid | Lymphatic system | CD11b antigen | Cell survival | Granulocyte-macrophage colony-stimulating factor | Neutrophils | CD62L protein | Leukocytes (neutrophilic) | Inflammation | Tumor cell lines | Gene expression | Chemotaxis | Survival | Molecular chains | Gelatinase B | Tumor necrosis factor | Medical prognosis | Cell size | Chemokines | Tumors | Cancer
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB122 - AB122
Neutrophil survival induced by TC-CM was mediated by GM-CSF. [...]TC-CM induced neutrophil activation (CD11b and CD66b up-regulation, CD62L shedding),... 
Studies | Leukocytes (neutrophilic) | Thyroid cancer | Gene expression | Neutrophils | Thyroid
Journal Article
Journal of Immunology, ISSN 0022-1767, 05/2017, Volume 198, Issue 9, pp. 3426 - 3435
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 04/2017, Volume 8, p. 424
Prolonged low-grade inflammation or smoldering inflammation is a hallmark of cancer. Mast cells form a heterogeneous population of immune cells with... 
Angiogenesis | Inflammation | Mast cells | Lymphangiogenesis | Cancer | angiogenesis | LYMPH-NODES | TUMOR ANGIOGENESIS | IMMUNOLOGY | mast cells | BREAST-CANCER | TO-MESENCHYMAL TRANSITION | inflammation | GASTRIC-CANCER | POOR-PROGNOSIS | PROSTATE-CANCER | lymphangiogenesis | cancer | PLATELET-ACTIVATING-FACTOR | ENDOTHELIAL GROWTH-FACTOR | IMMUNOGLOBULIN-E | Research | Oncology, Experimental
Journal Article
Journal Article
FEBS Journal, ISSN 1742-464X, 11/2014, Volume 281, Issue 22, pp. 5043 - 5053
Journal Article
The FEBS Journal, ISSN 1742-464X, 11/2014, Volume 281, Issue 22, pp. 5043 - 5053
Journal Article
AMERICAN JOURNAL OF CANCER RESEARCH, ISSN 2156-6976, 2014, Volume 4, Issue 2, pp. 172 - 181
Combination therapies for melanoma that target immune-regulatory networks are entering clinical practice, and more are under investigation in preclinical or... 
IMMUNITY | CD73 | melanoma | RECEPTOR | ANTITUMOR-ACTIVITY | COMBINATION | INHIBITION | ONCOLOGY | immunotherapy | adenosine receptor | REGULATORY T-CELLS | CTLA4 | CTLA-4 | BLOCKADE
Journal Article
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 07/2019, Volume 9
Journal Article